-
1
-
-
22544467264
-
Cardiotoxicity of cancer chemotherapy: Implications for children
-
Simbre, V. C.; Duffy, S. A.; Dadlani, G. H.; Miller, T. L.; Lipshultz, S. E. Cardiotoxicity of cancer chemotherapy: Implications for children. Paediatr. Drugs 7:187-202; 2005.
-
(2005)
Paediatr. Drugs
, vol.7
, pp. 187-202
-
-
Simbre, V.C.1
Duffy, S.A.2
Dadlani, G.H.3
Miller, T.L.4
Lipshultz, S.E.5
-
3
-
-
0035398020
-
Late mortality experience in five-year survivors of childhood and adolescent cancer: The Childhood Cancer Survivors Study
-
Mertens, A.; Yasui, Y.; Neglia, J. P.; Potter, J. D.; Nesbit, M. E.; Ruccione, K.; Smithson, W. A.; Robison, L. L. Late mortality experience in five-year survivors of childhood and adolescent cancer: The Childhood Cancer Survivors Study. J. Clin. Oncol. 19:3163-3172; 2001.
-
(2001)
J. Clin. Oncol
, vol.19
, pp. 3163-3172
-
-
Mertens, A.1
Yasui, Y.2
Neglia, J.P.3
Potter, J.D.4
Nesbit, M.E.5
Ruccione, K.6
Smithson, W.A.7
Robison, L.L.8
-
4
-
-
0032563825
-
Doxorubicin-induced cardiomyopthy
-
Singal, P. K.; Iliskovic, N. Doxorubicin-induced cardiomyopthy. N. Engl. J. Med. 339:900-905; 1998.
-
(1998)
N. Engl. J. Med
, vol.339
, pp. 900-905
-
-
Singal, P.K.1
Iliskovic, N.2
-
5
-
-
0001115439
-
Anthracycline-induced cardiotoxicity in children and young adults
-
Giantris, A.; Abdurrahman, L.; Hinkle, A.; Asselin, B.; Lipshultz, S. E. Anthracycline-induced cardiotoxicity in children and young adults. Crit. Rev. Oncol. Hematol. 27:53-68; 1998.
-
(1998)
Crit. Rev. Oncol. Hematol
, vol.27
, pp. 53-68
-
-
Giantris, A.1
Abdurrahman, L.2
Hinkle, A.3
Asselin, B.4
Lipshultz, S.E.5
-
6
-
-
0025637635
-
The impact of childhood cancer in the United States and the world
-
Bleyer, W. A. The impact of childhood cancer in the United States and the world. Cancer J. Clin. 40:354-367; 1990.
-
(1990)
Cancer J. Clin
, vol.40
, pp. 354-367
-
-
Bleyer, W.A.1
-
7
-
-
0026714331
-
The anthracyclines: Will we ever find a better doxorubicine?
-
Weiss, R. B. The anthracyclines: Will we ever find a better doxorubicine? Semin. Oncol. 19:670-686; 1992.
-
(1992)
Semin. Oncol
, vol.19
, pp. 670-686
-
-
Weiss, R.B.1
-
8
-
-
33747852312
-
Anthracyclines in early breast cancer
-
Wilson, K. S. Anthracyclines in early breast cancer. N. Engl. J. Med. 355:845; 2006.
-
(2006)
N. Engl. J. Med
, vol.355
, pp. 845
-
-
Wilson, K.S.1
-
9
-
-
0037102148
-
Doxorubicin treatment in vivo causes cytochrome C release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity, and Bcl-2:Bax ratio
-
Childs, A. C.; Phaneuf, S. L.; Dirks, A. J.; Phillips, T.; Leeuwenburgh, C. Doxorubicin treatment in vivo causes cytochrome C release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity, and Bcl-2:Bax ratio. Cancer Res. 62:4592-4598; 2002.
-
(2002)
Cancer Res
, vol.62
, pp. 4592-4598
-
-
Childs, A.C.1
Phaneuf, S.L.2
Dirks, A.J.3
Phillips, T.4
Leeuwenburgh, C.5
-
10
-
-
0002670847
-
Pathophysiology of anthracyclines cardiotoxicity
-
Bricker, J. T, Green, D. M, D'Angio, G. J, eds, New York: Wiley-Liss;
-
Herman, E. H.; Ferrans, V. J. Pathophysiology of anthracyclines cardiotoxicity. In: Bricker, J. T.; Green, D. M.; D'Angio, G. J., eds. Cardiac toxicity after treatment for childhood cancer. New York: Wiley-Liss; 1993:25-34.
-
(1993)
Cardiac toxicity after treatment for childhood cancer
, pp. 25-34
-
-
Herman, E.H.1
Ferrans, V.J.2
-
11
-
-
33745008604
-
Pathogenesis of cardiotoxicity induced by anthracyclines
-
Elliott, P. Pathogenesis of cardiotoxicity induced by anthracyclines. Semin. Oncol. 33:S2-S7; 2006.
-
(2006)
Semin. Oncol
, vol.33
-
-
Elliott, P.1
-
12
-
-
2642566088
-
Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity
-
Minotti, G.; Menna, P.; Salvatorelli, E.; Cairo, G.; Gianni, L. Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol. Rev. 56:185-229; 2004.
-
(2004)
Pharmacol. Rev
, vol.56
, pp. 185-229
-
-
Minotti, G.1
Menna, P.2
Salvatorelli, E.3
Cairo, G.4
Gianni, L.5
-
13
-
-
0037311110
-
Anthracycline-induced suppression of GATA-4 transcription factor: Implication in the regulation of cardiac myocyte apoptosis
-
Kim, Y.; Ma, A. G.; Kitta, K.; Fitch, S. N.; Ikeda, T.; Ihara, Y.; Simon, A. R.; Evans, T.; Suzuki, Y. J. Anthracycline-induced suppression of GATA-4 transcription factor: Implication in the regulation of cardiac myocyte apoptosis. Mol. Pharmacol. 63:368-377; 2003.
-
(2003)
Mol. Pharmacol
, vol.63
, pp. 368-377
-
-
Kim, Y.1
Ma, A.G.2
Kitta, K.3
Fitch, S.N.4
Ikeda, T.5
Ihara, Y.6
Simon, A.R.7
Evans, T.8
Suzuki, Y.J.9
-
14
-
-
0033965484
-
Mechanisms of doxorubicin-induced inhibition of sarcoplasmic reticulum CaATPase gene transcription
-
Arai, M.; Yoguchi, A.; Takizawa, T. Mechanisms of doxorubicin-induced inhibition of sarcoplasmic reticulum CaATPase gene transcription. Mol. Med. 86:8-14; 2000.
-
(2000)
Mol. Med
, vol.86
, pp. 8-14
-
-
Arai, M.1
Yoguchi, A.2
Takizawa, T.3
-
15
-
-
0032795759
-
Cardiotoxicity of cancer therapy
-
Tolba, K.; Deliargyris, E. N. Cardiotoxicity of cancer therapy. Cancer Invest. 17:408-422; 1999.
-
(1999)
Cancer Invest
, vol.17
, pp. 408-422
-
-
Tolba, K.1
Deliargyris, E.N.2
-
16
-
-
0035479423
-
Nuclear magnetic resonance study of doxorubicin binding to cardiolipin containing magnetically oriented phospholipid bilayers
-
Parker, M. A.; King, V.; Howard, K. P. Nuclear magnetic resonance study of doxorubicin binding to cardiolipin containing magnetically oriented phospholipid bilayers. Biochim. Biophys. Acta 1514:206-216; 2001.
-
(2001)
Biochim. Biophys. Acta
, vol.1514
, pp. 206-216
-
-
Parker, M.A.1
King, V.2
Howard, K.P.3
-
17
-
-
0024208168
-
Cardiac matrix alterations induced by adriamycin
-
Caulfield, J. B.; Bittner, V. Cardiac matrix alterations induced by adriamycin. Am. J. Pathol. 133:298-230; 1988.
-
(1988)
Am. J. Pathol
, vol.133
, pp. 298-230
-
-
Caulfield, J.B.1
Bittner, V.2
-
18
-
-
0035209431
-
Frequency-domain analysis of the QRS complex after treatment of childhood cancer with anthracycline cytostatics
-
Mladosievicova, B.; Foltinova, A.; Luptak, I.; Petrasova, H.; Hulin, I. Frequency-domain analysis of the QRS complex after treatment of childhood cancer with anthracycline cytostatics. Pediatr. Cardiol. 22:478-482; 2001.
-
(2001)
Pediatr. Cardiol
, vol.22
, pp. 478-482
-
-
Mladosievicova, B.1
Foltinova, A.2
Luptak, I.3
Petrasova, H.4
Hulin, I.5
-
19
-
-
33644633955
-
The anticancer drug, doxorubicin, causes oxidant stress-induced endothelial dysfunction
-
Wolf, M. B.; Baynes, J. W. The anticancer drug, doxorubicin, causes oxidant stress-induced endothelial dysfunction. Biochim. Biophys. Acta 1760:267-271; 2006.
-
(2006)
Biochim. Biophys. Acta
, vol.1760
, pp. 267-271
-
-
Wolf, M.B.1
Baynes, J.W.2
-
20
-
-
33744966574
-
Anthracycline-induced cardiotoxicity in adult hematologic malignancies
-
Johnson, S. A. Anthracycline-induced cardiotoxicity in adult hematologic malignancies. Semin. Oncol. 33:S22-S27; 2006.
-
(2006)
Semin. Oncol
, vol.33
-
-
Johnson, S.A.1
-
21
-
-
34548331601
-
Anthracycline cardiotoxicity in long-term survivors of childhood cancer
-
Scully, R. E.; Lipshultz, S. E. Anthracycline cardiotoxicity in long-term survivors of childhood cancer. Cardiovasc. Toxicol. 7:122-128; 2007.
-
(2007)
Cardiovasc. Toxicol
, vol.7
, pp. 122-128
-
-
Scully, R.E.1
Lipshultz, S.E.2
-
22
-
-
1542646978
-
Chemotherapy-related cardiotoxicity: New diagnostic and preventive strategies
-
Benvenuto, G. M.; Ometto, R.; Fontanelli, A.; Fortunate, A.; Ruffini, P. A.; Fosser, V.; Morandi, P. Chemotherapy-related cardiotoxicity: New diagnostic and preventive strategies. Ital. Heart J. 4:655-667; 2003.
-
(2003)
Ital. Heart J
, vol.4
, pp. 655-667
-
-
Benvenuto, G.M.1
Ometto, R.2
Fontanelli, A.3
Fortunate, A.4
Ruffini, P.A.5
Fosser, V.6
Morandi, P.7
-
23
-
-
33845507311
-
Biochemical markers for predicting chemotherapy induced cardiotoxicity: Systematic review of the literature and recommendations for use
-
Dolci, A.; Dominici, R.; Cardinale, D.; Sandri, M. T.; Panteghini, M. Biochemical markers for predicting chemotherapy induced cardiotoxicity: Systematic review of the literature and recommendations for use. J. Ital. Cardiol. 7:604-611; 2006.
-
(2006)
J. Ital. Cardiol
, vol.7
, pp. 604-611
-
-
Dolci, A.1
Dominici, R.2
Cardinale, D.3
Sandri, M.T.4
Panteghini, M.5
-
24
-
-
19444383085
-
Troponin as a marker of myocardial damage in drug-induced cardiotoxicity
-
Adamcova, M.; Sterba, M.; Simunek, T.; Potacova, A.; Popelova, O.; Mazurova, Y.; Gersl, V. Troponin as a marker of myocardial damage in drug-induced cardiotoxicity. Expert Opin. Drug. Saf. 4:457-472; 2005.
-
(2005)
Expert Opin. Drug. Saf
, vol.4
, pp. 457-472
-
-
Adamcova, M.1
Sterba, M.2
Simunek, T.3
Potacova, A.4
Popelova, O.5
Mazurova, Y.6
Gersl, V.7
-
25
-
-
0031834174
-
Natriuretic peptides: Physiology, therapeutic potential, and risk stratification in ischemic heart disease
-
Stein, B. C.; Levin, R. I. Natriuretic peptides: Physiology, therapeutic potential, and risk stratification in ischemic heart disease. Am. Heart. J. 135:914-923; 1998.
-
(1998)
Am. Heart. J
, vol.135
, pp. 914-923
-
-
Stein, B.C.1
Levin, R.I.2
-
26
-
-
27444437297
-
Clinical usefulness of B-type natriuretic peptide measurement: Present and future perspectives
-
Bettencourt, P. M. Clinical usefulness of B-type natriuretic peptide measurement: Present and future perspectives. Heart 91:1489-1494; 2005.
-
(2005)
Heart
, vol.91
, pp. 1489-1494
-
-
Bettencourt, P.M.1
-
28
-
-
1342312430
-
-
Vanderheyde, M.; Bartunek, J.; Goethals, M. Brain and other natriuretic peptides: Molecular aspects. Eur. J. Heart Fail. 6:261-268; 2004.
-
Vanderheyde, M.; Bartunek, J.; Goethals, M. Brain and other natriuretic peptides: Molecular aspects. Eur. J. Heart Fail. 6:261-268; 2004.
-
-
-
-
29
-
-
0030013030
-
New insight into the cardiac natriuretic peptides
-
Bonow, R. O. New insight into the cardiac natriuretic peptides. Circulation 93:1946-1950; 1996.
-
(1996)
Circulation
, vol.93
, pp. 1946-1950
-
-
Bonow, R.O.1
-
30
-
-
0036089912
-
Role of cardiac natriuretic peptide testing in heart failure
-
Mair, J. Role of cardiac natriuretic peptide testing in heart failure. Clin. Chem. 48:977-978; 2002.
-
(2002)
Clin. Chem
, vol.48
, pp. 977-978
-
-
Mair, J.1
-
31
-
-
33645791709
-
Clinical relevance of biological variation: The lesson of brain natriuretic peptide (BNP) and NT-proBNP assay
-
Clerico, A.; Zucchelli, G. C.; Pilo, A.; Passino, C.; Emdin, M. Clinical relevance of biological variation: The lesson of brain natriuretic peptide (BNP) and NT-proBNP assay. Clin. Chem. Lab. Med. 44:366-378; 2006.
-
(2006)
Clin. Chem. Lab. Med
, vol.44
, pp. 366-378
-
-
Clerico, A.1
Zucchelli, G.C.2
Pilo, A.3
Passino, C.4
Emdin, M.5
-
32
-
-
34247135389
-
Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: The STARS-BNP Multicenter Study
-
Jourdain, P.; Jondeau, G.; Funck, F.; Gueffet, P.; Le Helloco, A.; Donal, E.; Aupetit, J. F.; Aumont, M. C.; Galinier, M.; Eicher, J. C.; Cohen-Solal, A.; Juillière, Y. Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: The STARS-BNP Multicenter Study. J. Am. Coll. Cardiol. 49:1733-1739; 2007.
-
(2007)
J. Am. Coll. Cardiol
, vol.49
, pp. 1733-1739
-
-
Jourdain, P.1
Jondeau, G.2
Funck, F.3
Gueffet, P.4
Le Helloco, A.5
Donal, E.6
Aupetit, J.F.7
Aumont, M.C.8
Galinier, M.9
Eicher, J.C.10
Cohen-Solal, A.11
Juillière, Y.12
-
33
-
-
14844333579
-
B-type natriuretic peptide levels are not a surrogate marker for invasive hemodynamics during management of patients with severe heart failure
-
O'Neill, J. O.; Bott-Silverman, C. E.; McRae, 3rd, A. T.; Troughton, R. W.; Ng, K.; Starling, R. C.; Young, J. B. B-type natriuretic peptide levels are not a surrogate marker for invasive hemodynamics during management of patients with severe heart failure. Am. Heart J. 149:363-369; 2005
-
(2005)
Am. Heart J
, vol.149
, pp. 363-369
-
-
O'Neill, J.O.1
Bott-Silverman, C.E.2
McRae 3rd, A.T.3
Troughton, R.W.4
Ng, K.5
Starling, R.C.6
Young, J.B.7
-
34
-
-
11844290705
-
Natriuretic peptides in the monitoring of anthracycline induced reduction in left ventricular ejection fraction
-
Daugaard, G.; Lassen, U.; Bie, P.; Pedersen, E. B.; Jensen, K. T.; Abildgaard, U.; Hesse, B.; Kjaer, A. Natriuretic peptides in the monitoring of anthracycline induced reduction in left ventricular ejection fraction. Eur. J. Heart Fail. 7:87-93; 2005.
-
(2005)
Eur. J. Heart Fail
, vol.7
, pp. 87-93
-
-
Daugaard, G.1
Lassen, U.2
Bie, P.3
Pedersen, E.B.4
Jensen, K.T.5
Abildgaard, U.6
Hesse, B.7
Kjaer, A.8
-
35
-
-
0026570936
-
Atrial natriuretic peptide as a marker for doxorubicin induced cardiotoxic effects
-
Bauch, M.; Ester, A.; Kimura, B.; Victorica, B. E.; Kedar, A.; Phillips, M. I. Atrial natriuretic peptide as a marker for doxorubicin induced cardiotoxic effects. Cancer 69:1492-1497; 1992.
-
(1992)
Cancer
, vol.69
, pp. 1492-1497
-
-
Bauch, M.1
Ester, A.2
Kimura, B.3
Victorica, B.E.4
Kedar, A.5
Phillips, M.I.6
-
36
-
-
0031856391
-
Serum N-terminal atrial natriuretic peptide (NTANP) in the cardiac follow-up in children with cancer
-
Tikanoja, T.; Riikonen, P.; Perkkio, M.; Helenius, T. Serum N-terminal atrial natriuretic peptide (NTANP) in the cardiac follow-up in children with cancer. Med. Pediatr. Oncol. 31:73-78; 1998.
-
(1998)
Med. Pediatr. Oncol
, vol.31
, pp. 73-78
-
-
Tikanoja, T.1
Riikonen, P.2
Perkkio, M.3
Helenius, T.4
-
37
-
-
0037811735
-
Long-term prospective follow-up study of cardiac function after cardiotoxic therapy for malignancy in children
-
Poutanen, T.; Tikanoja, T.; Riikonen, P.; Silvast, A.; Perkkio, M. Long-term prospective follow-up study of cardiac function after cardiotoxic therapy for malignancy in children. J. Clin. Oncol. 21:2349-2356; 2003.
-
(2003)
J. Clin. Oncol
, vol.21
, pp. 2349-2356
-
-
Poutanen, T.1
Tikanoja, T.2
Riikonen, P.3
Silvast, A.4
Perkkio, M.5
-
38
-
-
0034964104
-
Plasma levels of natriuretic peptides in relation to doxorubicin-induced cardiotoxicity and cardiac function in children with cancer
-
Hayakawa, H.; Komada, Y.; Hirayama, M.; Hori, H.; Ito, M.; Sakurai, M. Plasma levels of natriuretic peptides in relation to doxorubicin-induced cardiotoxicity and cardiac function in children with cancer. Med. Pediatr. Oncol. 37:4-9; 2001.
-
(2001)
Med. Pediatr. Oncol
, vol.37
, pp. 4-9
-
-
Hayakawa, H.1
Komada, Y.2
Hirayama, M.3
Hori, H.4
Ito, M.5
Sakurai, M.6
-
39
-
-
24744439974
-
Plasma concentrations of NT-pro-BNP and cardiac troponin-I in relation to doxorubicin-induced cardiomyopathy and cardiac function in childhood malignancy
-
Soker, M.; Kervancioglu, M. Plasma concentrations of NT-pro-BNP and cardiac troponin-I in relation to doxorubicin-induced cardiomyopathy and cardiac function in childhood malignancy. Saudi Med. J. 26:1197-1202; 2005.
-
(2005)
Saudi Med. J
, vol.26
, pp. 1197-1202
-
-
Soker, M.1
Kervancioglu, M.2
-
40
-
-
44849141771
-
Accelerated atherosclerosis contributes to elevated global risk for premature symptomatic cardiovascular disease in survivors of childhood cancer
-
Abstract No
-
Lipshultz, S. E.; Hinkle, A. S.; French, C. A.; Kozlowski, A. M.; Constine, L. S. Accelerated atherosclerosis contributes to elevated global risk for premature symptomatic cardiovascular disease in survivors of childhood cancer. Abstract No: 3203, ASCO Annual Meeting; 2003.
-
(2003)
3203, ASCO Annual Meeting
-
-
Lipshultz, S.E.1
Hinkle, A.S.2
French, C.A.3
Kozlowski, A.M.4
Constine, L.S.5
-
41
-
-
33644685056
-
Correlation of plasma N-terminal probrain natriuretic peptide levels with left ventricle mass in children treated with anthracyclines
-
Germanakis, I.; Kalmanti, M.; Parthenakis, F.; Nikitovic, D.; Stiakaki, E.; Patrianakos, A.; Vardas, P. E. Correlation of plasma N-terminal probrain natriuretic peptide levels with left ventricle mass in children treated with anthracyclines. Int. J. Cardiol. 108:212-215; 2006.
-
(2006)
Int. J. Cardiol
, vol.108
, pp. 212-215
-
-
Germanakis, I.1
Kalmanti, M.2
Parthenakis, F.3
Nikitovic, D.4
Stiakaki, E.5
Patrianakos, A.6
Vardas, P.E.7
-
42
-
-
0031793722
-
Acute neurohumoral and cardiovascular effects of idarubicin in leukemia patients
-
Nousiainen, T.; Jantunen, E.; Vanninen, E.; Remes, J.; Puustinen, J.; Rantala, A.; Vuolteenaho, O.; Hartikainen, J. Acute neurohumoral and cardiovascular effects of idarubicin in leukemia patients. Eur. J. Haematol. 61:347-353; 1998.
-
(1998)
Eur. J. Haematol
, vol.61
, pp. 347-353
-
-
Nousiainen, T.1
Jantunen, E.2
Vanninen, E.3
Remes, J.4
Puustinen, J.5
Rantala, A.6
Vuolteenaho, O.7
Hartikainen, J.8
-
43
-
-
0032909472
-
Natriuretic peptides as markers of cardiotoxicity during doxorubicin treatment for non-Hodgkin's lymphoma
-
Nousiainen, T.; Jantunen, E.; Vanninen, E.; Remes, J.; Vuolteenaho, O.; Hartikainen, J. Natriuretic peptides as markers of cardiotoxicity during doxorubicin treatment for non-Hodgkin's lymphoma. Eur. J. Haematol. 62:135-141; 1999.
-
(1999)
Eur. J. Haematol
, vol.62
, pp. 135-141
-
-
Nousiainen, T.1
Jantunen, E.2
Vanninen, E.3
Remes, J.4
Vuolteenaho, O.5
Hartikainen, J.6
-
44
-
-
0035212366
-
Neuroendocrine changes during the evolution of doxorubicin-induced left ventricular dysfunction in adult lymphoma patients
-
Nousiainen, T.; Vanninen, E.; Jantunen, E.; Remes, J.; Ritanen, E.; Vuolteenaho, O.; Hartikainen, J. Neuroendocrine changes during the evolution of doxorubicin-induced left ventricular dysfunction in adult lymphoma patients. Clin. Sci. (Lond.) 101:601-607; 2001.
-
(2001)
Clin. Sci. (Lond.)
, vol.101
, pp. 601-607
-
-
Nousiainen, T.1
Vanninen, E.2
Jantunen, E.3
Remes, J.4
Ritanen, E.5
Vuolteenaho, O.6
Hartikainen, J.7
-
45
-
-
0036124132
-
Natriuretic peptides during the development of doxorubicin-induced left ventricular diastolic dysfunction
-
Nousiainen, T.; Vanninen, E.; Jantunen, E.; Puustinen, J.; Remes, J.; Rantala, A.; Vuolteenaho, O.; Hartikainen, J. Natriuretic peptides during the development of doxorubicin-induced left ventricular diastolic dysfunction. J. Intern. Med. 251:228-234; 2002.
-
(2002)
J. Intern. Med
, vol.251
, pp. 228-234
-
-
Nousiainen, T.1
Vanninen, E.2
Jantunen, E.3
Puustinen, J.4
Remes, J.5
Rantala, A.6
Vuolteenaho, O.7
Hartikainen, J.8
-
46
-
-
17744400311
-
Brain natriuretic peptide is a predictor of anthracycline-induced cardiotoxicity
-
Okumura, H.; Iuchi, K.; Yoshida, T.; Nakamura, S.; Takeshima, M.; Takamatsu, H.; Ikeno, A.; Usuda, K.; Ishikawa, T.; Ohtake, S.; Matsuda, T. Brain natriuretic peptide is a predictor of anthracycline-induced cardiotoxicity. Acta Haematol. 104:158-163; 2000.
-
(2000)
Acta Haematol
, vol.104
, pp. 158-163
-
-
Okumura, H.1
Iuchi, K.2
Yoshida, T.3
Nakamura, S.4
Takeshima, M.5
Takamatsu, H.6
Ikeno, A.7
Usuda, K.8
Ishikawa, T.9
Ohtake, S.10
Matsuda, T.11
-
47
-
-
0031848104
-
Elevated B-type natriuretic peptide levels after anthracycline administration
-
Suzuki, T.; Hayashi, D.; Yamazaki, T.; Mizuno, T.; Kanda, Y.; Komuro, I.; Kurabayashi, M.; Yamaoki, K.; Mitani, K.; Hirai, H.; Nagai, R.; Yazaki, Y. Elevated B-type natriuretic peptide levels after anthracycline administration. Am. Heart J. 136:362-363; 1998.
-
(1998)
Am. Heart J
, vol.136
, pp. 362-363
-
-
Suzuki, T.1
Hayashi, D.2
Yamazaki, T.3
Mizuno, T.4
Kanda, Y.5
Komuro, I.6
Kurabayashi, M.7
Yamaoki, K.8
Mitani, K.9
Hirai, H.10
Nagai, R.11
Yazaki, Y.12
-
48
-
-
23044510968
-
N-terminal pro-B-type natriuretic peptide after high-dose chemotherapy: A marker predictive of cardiac dysfunction?
-
Sandri, M. T.; Salvatici, M.; Cardinale, D.; Zorzino, L.; Passerini, R.; Lentati, P.; Leon, M.; Civelli, M.; Martinelli, G.; Cipolla, C. M. N-terminal pro-B-type natriuretic peptide after high-dose chemotherapy: A marker predictive of cardiac dysfunction? Clin. Chem. 51:1405-1410; 2005.
-
(2005)
Clin. Chem
, vol.51
, pp. 1405-1410
-
-
Sandri, M.T.1
Salvatici, M.2
Cardinale, D.3
Zorzino, L.4
Passerini, R.5
Lentati, P.6
Leon, M.7
Civelli, M.8
Martinelli, G.9
Cipolla, C.M.10
-
49
-
-
33745746827
-
Comparison of plasmatic levels of B-natriuretic peptide with echocardiographicindicators of left ventricle function after doxorubicin therapy
-
Elbl, L.; Vasova, I.; Navratil, M.; Vorlicek, J.; Malaskova, L.; Spinar, J. Comparison of plasmatic levels of B-natriuretic peptide with echocardiographicindicators of left ventricle function after doxorubicin therapy. Vnitr. Lek. 52:563-570; 2006.
-
(2006)
Vnitr. Lek
, vol.52
, pp. 563-570
-
-
Elbl, L.1
Vasova, I.2
Navratil, M.3
Vorlicek, J.4
Malaskova, L.5
Spinar, J.6
-
50
-
-
0025826438
-
Preliminary study on behaviour of atrial natriuretic factor in anthracycline-related cardiac toxicity
-
Neri, B.; De Scalzi, M.; De Leonardis, V.; Gemelli, M. T.; Ghezzi, P.; Pacini, P. Preliminary study on behaviour of atrial natriuretic factor in anthracycline-related cardiac toxicity. Int. J. Clin. Pharmacol. Res. 11:75-81; 1991.
-
(1991)
Int. J. Clin. Pharmacol. Res
, vol.11
, pp. 75-81
-
-
Neri, B.1
De Scalzi, M.2
De Leonardis, V.3
Gemelli, M.T.4
Ghezzi, P.5
Pacini, P.6
-
51
-
-
0035873830
-
Prospective evaluation of early cardiac damage induced by epirubicin-containing adjuvant chemotherapy and locoregional radiotherapy in breast cancer patients
-
Meinardi, M. T.; van Veldhuisen, D. J.; Gietema, J. A.; Dolsma, W. V.; Boomsma, F.; van den Berg, M. P.; Volkers, C.; Haaksma, J.; de Vries, E. G.; Sleijfer, D. T.; van der Graaf, W. T. Prospective evaluation of early cardiac damage induced by epirubicin-containing adjuvant chemotherapy and locoregional radiotherapy in breast cancer patients. J. Clin. Oncol. 19:2746-2753; 2001.
-
(2001)
J. Clin. Oncol
, vol.19
, pp. 2746-2753
-
-
Meinardi, M.T.1
van Veldhuisen, D.J.2
Gietema, J.A.3
Dolsma, W.V.4
Boomsma, F.5
van den Berg, M.P.6
Volkers, C.7
Haaksma, J.8
de Vries, E.G.9
Sleijfer, D.T.10
van der Graaf, W.T.11
-
52
-
-
23344445036
-
Use of natriuretic peptides for detecting cardiac dysfunction in long-term disease-free breast cancer survivors
-
Perik, P. J.; De Vries, E. G.; Boomsma, F.; van der Graaf, W. T.; Sleijfer, D. T.; van Veldhuisen, D. J.; Gietema, J. A. Use of natriuretic peptides for detecting cardiac dysfunction in long-term disease-free breast cancer survivors. Anticancer Res. 25:3651-3657; 2005.
-
(2005)
Anticancer Res
, vol.25
, pp. 3651-3657
-
-
Perik, P.J.1
De Vries, E.G.2
Boomsma, F.3
van der Graaf, W.T.4
Sleijfer, D.T.5
van Veldhuisen, D.J.6
Gietema, J.A.7
-
53
-
-
17644388763
-
Drug-induced cardiotoxicity studied by longitudinal B-type natriuretic peptide assays and radionuclide ventriculography
-
Pichon, M. F.; Cvitkovic, F.; Hacene, K.; van der Graaf, W. T.; Sleijfer, D. T.; van Veldhuisen, D. J.; Gietema, J. A. Drug-induced cardiotoxicity studied by longitudinal B-type natriuretic peptide assays and radionuclide ventriculography. In Vivo 19:567-576; 2005.
-
(2005)
In Vivo
, vol.19
, pp. 567-576
-
-
Pichon, M.F.1
Cvitkovic, F.2
Hacene, K.3
van der Graaf, W.T.4
Sleijfer, D.T.5
van Veldhuisen, D.J.6
Gietema, J.A.7
-
54
-
-
33750303897
-
Serial testing of B-type natriuretic peptide and NTpro-BNP for monitoring therapy of heart failure: The role of biologic variation in the interpretation of results
-
Wu, A. H. Serial testing of B-type natriuretic peptide and NTpro-BNP for monitoring therapy of heart failure: The role of biologic variation in the interpretation of results. Am. Heart J. 152:828-834; 2006.
-
(2006)
Am. Heart J
, vol.152
, pp. 828-834
-
-
Wu, A.H.1
-
55
-
-
7044284668
-
High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure
-
Bruins, S.; Fokkema, M. R.; Romer, J. W.; Dejongste, M. J.; van der Dijs, F. P.; van den Ouweland, J. M.; Muskiet, F. A. High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure. Clin. Chem. 50:2052-2058; 2004.
-
(2004)
Clin. Chem
, vol.50
, pp. 2052-2058
-
-
Bruins, S.1
Fokkema, M.R.2
Romer, J.W.3
Dejongste, M.J.4
van der Dijs, F.P.5
van den Ouweland, J.M.6
Muskiet, F.A.7
|